PPARGC1A and diabetic cardiomyopathy: Sulforaphane was shown to prevent the decreased expression of Sirt1 and Pgc-1α in an animal model of T2DM, as a protective mechanism against diabetic cardiomyopathy [32] and muscle atrophy [33].